CoChat
Sign Up
Cited by 75

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Activated Ras Signals Developmental Progression of Recombinase-activating Gene (RAG)-deficient Pro-B Lymphocytes

Shaw, Albert C., Swat, Wojciech, Ferrini, Roger, Davidson, Laurie, Alt, Frederick W.·1999·The Journal of Experimental Medicine
DOI 10.1084/jem.189.1.123PMC PMC1887686
Open this paper in CoChat — free account

Abstract

To elucidate the intracellular pathways that mediate early B cell development, we directed expression of activated Ras to the B cell lineage in the context of the recombination-activating gene 1 (RAG1)-deficient background (referred to as Ras–RAG). Similar to the effects of an immunoglobulin (Ig) μ heavy chain (HC) transgene, activated Ras caused progression of RAG1–deficient progenitor (pro)-B cells to cells that shared many characteristics with precursor (pre)-B cells, including downregulation of surface CD43 expression plus expression of λ5, RAG2, and germline κ locus transcripts. However, these Ras–RAG pre-B cells also upregulated surface markers characteristic of more mature B cell stages and populated peripheral lymphoid tissues, with an overall phenotype reminiscent of B lineage cells generated in a RAG- deficient background as a result of expression of an Ig μ HC together with a Bcl-2 transgene. Taken together, these findings suggest that activated Ras signaling in pro-B cells induces developmental progression by activating both differentiation and survival signals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.189.1.123

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Activated c-Ha-Ras expression vector and Western blot analysis of c-Ha-Ras expression. (A) Diagram of the pEμRasV12 expression vector. Eμ, Ig HC enhancer; VH, HC variable region promoter; Ras, c-Ha-ras V12 cDNA; β-globin, β-globin exons 2 and 3 with polyadenylation signal. (B) Western blot analysis of total spleen or lymph node lysates from a Ras–RAG1−/−, RAG2-deficient chimera and RAG2-deficient mouse, probed with a monoclonal antibody against Ha-ras. The position of p21 Ha-ras is indicated by the arrow. Ponceau-S staining was employed to verify equivalent loading of protein. Lane 1, Ras–RAG1−/− total lymph node; lane 2, Ras–RAG1−/− total spleen; lane 3, RAG2−/− total spleen.
Figure 1 Activated c-Ha-Ras expression vector and Western blot analysis of c-Ha-Ras expression. (A) Diagram of the pEμRasV12 expression vector. Eμ, Ig HC enhancer; VH, HC variable region promoter; Ras, c-Ha-ras V12 cDNA; β-globin, β-globin exons 2 and 3 with polyadenylation signal. (B) Western blot analysis of total spleen or lymph node lysates from a Ras–RAG1−/−, RAG2-deficient chimera and RAG2-deficient mouse, probed with a monoclonal antibody against Ha-ras. The position of p21 Ha-ras is indicated by the arrow. Ponceau-S staining was employed to verify equivalent loading of protein. Lane 1, Ras–RAG1−/− total lymph node; lane 2, Ras–RAG1−/− total spleen; lane 3, RAG2−/− total spleen.CC BY-NC-SA · PubMed Central
Figure 2 Surface phenotype of Ras–RAG B lineage cells. Lymphocytes isolated from lymph node of Ras–RAG1−/−, RAG2-deficient chimera, RAG2−/−, and wild-type (129 Sv/Ev) mice were subjected to FACS® analyses. Depicted are log-scale dot plots of B220 versus CD43, IgM, CD23, and CD21/CD35. The plots reflect 20,000 collected events, with dead cells excluded by forward and side scatter. Similar results were found in the spleen. Results shown are representative of those obtained in the analysis of six chimeric mice derived from two independent transfected ES clones. The number of B220+Ly9.1+ cells in these RAG2-deficient chimeras ranged from 5 × 105 to 1.6 × 107 in lymph node and 2 × 106 to 7 × 106 in spleen. Chimeric animals analyzed for evidence of B cell developmental progression showed no gross evidence of malignancy. Older chimeric mice do tend to develop B lineage lymphomas, but such transformed cells are significantly larger in cell size and have markedly altered surface antigen staining characteristics (data not shown). Ras-Rag, activated Ras-complemented-RAG1–/–, RAG2-deficient chimera; Rag, RAG2−/− mouse.
Figure 2 Surface phenotype of Ras–RAG B lineage cells. Lymphocytes isolated from lymph node of Ras–RAG1−/−, RAG2-deficient chimera, RAG2−/−, and wild-type (129 Sv/Ev) mice were subjected to FACS® analyses. Depicted are log-scale dot plots of B220 versus CD43, IgM, CD23, and CD21/CD35. The plots reflect 20,000 collected events, with dead cells excluded by forward and side scatter. Similar results were found in the spleen. Results shown are representative of those obtained in the analysis of six chimeric mice derived from two independent transfected ES clones. The number of B220+Ly9.1+ cells in these RAG2-deficient chimeras ranged from 5 × 105 to 1.6 × 107 in lymph node and 2 × 106 to 7 × 106 in spleen. Chimeric animals analyzed for evidence of B cell developmental progression showed no gross evidence of malignancy. Older chimeric mice do tend to develop B lineage lymphomas, but such transformed cells are significantly larger in cell size and have markedly altered surface antigen staining characteristics (data not shown). Ras-Rag, activated Ras-complemented-RAG1–/–, RAG2-deficient chimera; Rag, RAG2−/− mouse.CC BY-NC-SA · PubMed Central
Figure 3 Analysis of λ5 and RAG expression. RNA isolated from Ras–RAG1−/− (Ras-Rag), wild-type mature B (WT B), and wild-type pre-B (WT Pre-B) lymphocytes purified from lymph node and spleen was reverse transcribed, and first-strand cDNA was subjected to PCR analysis using λ5, RAG2, and β-actin primer pairs (see Materials and Methods). For each B lineage cell type, serial fivefold dilutions are shown. ES cell cDNA was added to the 5- and 25-fold dilutions of each B lineage cDNA sample to equalize template quantity. Single lanes containing no cDNA (H2O) or ES cDNA alone are shown for each primer pair.
Figure 3 Analysis of λ5 and RAG expression. RNA isolated from Ras–RAG1−/− (Ras-Rag), wild-type mature B (WT B), and wild-type pre-B (WT Pre-B) lymphocytes purified from lymph node and spleen was reverse transcribed, and first-strand cDNA was subjected to PCR analysis using λ5, RAG2, and β-actin primer pairs (see Materials and Methods). For each B lineage cell type, serial fivefold dilutions are shown. ES cell cDNA was added to the 5- and 25-fold dilutions of each B lineage cDNA sample to equalize template quantity. Single lanes containing no cDNA (H2O) or ES cDNA alone are shown for each primer pair.CC BY-NC-SA · PubMed Central
Figure 4 κ light chain locus germline transcripts are upregulated in Ras–RAG B lineage cells. RNAs from sorted B220+ Ly 9.1+Ras– RAG1−/− (Ras-Rag) B lineage cells, from B220+ CD43−IgM− wild-type pre-B cells (WT Pre-B), and from B220+CD43+ RAG2-deficient pro-B cells (Rag Pro-B) were subjected to RT-PCR analysis for detection of germline κ transcripts. Serial fivefold dilutions are shown, and ES cell cDNA was diluted into 5- and 25-fold dilutions. Samples with (+) and without (–) reverse transcriptase are indicated.
Figure 4 κ light chain locus germline transcripts are upregulated in Ras–RAG B lineage cells. RNAs from sorted B220+ Ly 9.1+Ras– RAG1−/− (Ras-Rag) B lineage cells, from B220+ CD43−IgM− wild-type pre-B cells (WT Pre-B), and from B220+CD43+ RAG2-deficient pro-B cells (Rag Pro-B) were subjected to RT-PCR analysis for detection of germline κ transcripts. Serial fivefold dilutions are shown, and ES cell cDNA was diluted into 5- and 25-fold dilutions. Samples with (+) and without (–) reverse transcriptase are indicated.CC BY-NC-SA · PubMed Central
Figure 5 Analysis of Bcl-2 and Bcl-xL expression. RNAs from sorted Ras–RAG1−/− (Ras-Rag), mature wild-type B (WT B), and wild-type pre-B (WT Pre-B) lymphocytes were subjected to RT-PCR analysis, using β-actin expression as a standard. Serial fivefold dilutions are shown for each B lineage cell type.
Figure 5 Analysis of Bcl-2 and Bcl-xL expression. RNAs from sorted Ras–RAG1−/− (Ras-Rag), mature wild-type B (WT B), and wild-type pre-B (WT Pre-B) lymphocytes were subjected to RT-PCR analysis, using β-actin expression as a standard. Serial fivefold dilutions are shown for each B lineage cell type.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. Willerford, 1996, Developmental regulation of V(D)J recombination and lymphocyte differentiation, Curr Opin Genet Dev, 6, 603, 10.1016/S0959-437X(96)80090-6 · DOI
  2. Karasuyama, 1996, Surrogate light chain in B cell development, Adv Immunol, 63, 1, 10.1016/S0065-2776(08)60853-6 · DOI
  3. Kitamura, 1991, A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ gene, Nature, 350, 423, 10.1038/350423a0 · DOI · Paper page
  4. Shinkai, 1992, RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement, Cell, 68, 855, 10.1016/0092-8674(92)90029-C · DOI
  5. Mombaerts, 1992, RAG-1-deficient mice have no mature B and T lymphocytes, Cell, 68, 869, 10.1016/0092-8674(92)90030-G · DOI
  6. Young, 1994, Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation, Genes Dev, 8, 1043, 10.1101/gad.8.9.1043 · DOI
  7. Spanopoulou, 1994, Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice, Genes Dev, 8, 1030, 10.1101/gad.8.9.1030 · DOI
  8. Reth, 1989, Antigen receptor tail clue, Nature, 338, 383, 10.1038/338383b0 · DOI
  9. Gong, 1996, Regulation of an early developmental checkpoint in the B cell pathway by Igβ, Science, 272, 411, 10.1126/science.272.5260.411 · DOI · Paper page
  10. Torres, 1996, Aberrant B cell development and immune response in mice with a compromised BCR complex, Science, 272, 1804, 10.1126/science.272.5269.1804 · DOI · Paper page
  11. Cheng, 1995, Syk tyrosine kinase required for mouse viability and B-cell development, Nature, 378, 303, 10.1038/378303a0 · DOI · Paper page
  12. Turner, 1995, Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk, Nature, 378, 298, 10.1038/378298a0 · DOI · Paper page
  13. DeFranco, 1997, The complexity of signaling pathways activated by the BCR, Curr Opin Immunol, 9, 296, 10.1016/S0952-7915(97)80074-X · DOI · Paper page
  14. Boguski, 1993, Proteins regulating Ras and its relatives, Nature, 366, 643, 10.1038/366643a0 · DOI
  15. Kazlauskas, 1994, Receptor tyrosine kinases and their targets, Curr Opin Genet Dev, 4, 5, 10.1016/0959-437X(94)90085-X · DOI
  16. Swat, 1996, Activated Ras signals differentiation and expansion of CD4+8+thymocytes, Proc Natl Acad Sci USA, 93, 4683, 10.1073/pnas.93.10.4683 · DOI
  17. Lazarus, 1993, Antigen-induced B lymphocyte activation involves the p21rasand ras GAP signaling pathway, J Exp Med, 178, 1765, 10.1084/jem.178.5.1765 · DOI
  18. Harwood, 1993, B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras1, J Immunol, 151, 4513, 10.4049/jimmunol.151.9.4513 · DOI
  19. Blankenstein, 1988, A retroviral expression vector containing murine immunoglobulin heavy chain promoter/enhancer, Nucleic Acids Res, 16, 10939, 10.1093/nar/16.22.10939 · DOI
  20. Shibuya, 1992, Oncogenic Ras triggers the activation of 42-kDa mitogen-activated protein kinase in extracts of quiescent Xenopus oocytes, Proc Natl Acad Sci USA, 89, 9831, 10.1073/pnas.89.20.9831 · DOI
  21. Chen, 1993, RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development, Proc Natl Acad Sci USA, 90, 4528, 10.1073/pnas.90.10.4528 · DOI
  22. Young, 1997, Constitutive Bcl-2 expression during immunoglobulin heavy chain-promoted B cell differentiation expands novel precursor B cells, Immunity, 6, 23, 10.1016/S1074-7613(00)80239-3 · DOI
  23. Li, 1993, The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver, J Exp Med, 178, 951, 10.1084/jem.178.3.951 · DOI
  24. Schneider, 1997, Bcl-x protects primary B cells against Fas-mediated apoptosis, J Immunol, 159, 4834, 10.4049/jimmunol.159.10.4834 · DOI
  25. Schlissel, 1989, Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription, Cell, 58, 1001, 10.1016/0092-8674(89)90951-3 · DOI
  26. Gorman, 1996, The Igκ 3′ enhancer influences the ratio of Igκ versus Igλ B lymphocytes, Immunity, 5, 241, 10.1016/S1074-7613(00)80319-2 · DOI
  27. Leon, 1987, Differential expression of the ras gene family in mice, Mol Cell Biol, 7, 1535
  28. Grawunder, 1995, Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement, Immunity, 3, 601, 10.1016/1074-7613(95)90131-0 · DOI
  29. Alt, 1981, Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: rearrangement of heavy but not light chain genes, Cell, 27, 381, 10.1016/0092-8674(81)90421-9 · DOI
  30. Ritchie, 1984, Allelic exclusion and control of endogenous immunoglobulin gene rearrangement in κ transgenic mice, Nature, 312, 517, 10.1038/312517a0 · DOI
  31. Reth, 1985, Regulated progression of a cultured pre-B cell line to the B cell stage, Nature, 317, 353, 10.1038/317353a0 · DOI
  32. Reth, 1987, Activation of V kappa gene rearrangement in pre-B cells follows the expression of membrane-bound immunoglobulin heavy chains, EMBO (Eur Mol Biol Organ) J, 6, 3299, 10.1002/j.1460-2075.1987.tb02649.x · DOI
  33. Nussenzweig, 1987, Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin μ, Science, 236, 816, 10.1126/science.3107126 · DOI
  34. Tedder, 1997, CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling, Annu Rev Immunol, 15, 481, 10.1146/annurev.immunol.15.1.481 · DOI
  35. Tedder, 1997, The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity, Immunity, 6, 107, 10.1016/S1074-7613(00)80418-5 · DOI
  36. Tarlinton, 1997, Continued differentiation during B lymphopoiesis requires signals in addition to cell survival, Int Immunol, 9, 1481, 10.1093/intimm/9.10.1481 · DOI
  37. Merino, 1994, Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes, EMBO (Eur Mol Biol Organ) J, 13, 683, 10.1002/j.1460-2075.1994.tb06307.x · DOI
  38. Choi, 1996, Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli, Eur J Immunol, 26, 676, 10.1002/eji.1830260325 · DOI
  39. Hikida, 1996, Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells, Science, 274, 2092, 10.1126/science.274.5295.2092 · DOI
  40. Han, 1996, Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells, Science, 274, 2094, 10.1126/science.274.5295.2094 · DOI
  41. Han, 1997, V(D)J recombinase activity in a subset of germinal center B lymphocytes, Science, 278, 301, 10.1126/science.278.5336.301 · DOI
  42. Kelsoe, 1995, In situ studies of the germinal center reaction, Adv Immunol, 60, 267, 10.1016/S0065-2776(08)60587-8 · DOI
  43. Marshall, 1995, Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation, Cell, 80, 179, 10.1016/0092-8674(95)90401-8 · DOI · Paper page
  44. Su, 1996, Mitogen-activated protein kinase cascades and regulation of gene expression, Curr Opin Immunol, 8, 402, 10.1016/S0952-7915(96)80131-2 · DOI · Paper page
  45. Rodriguez-Viciana, 1996, Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation, EMBO (Eur Mol Biol Organ) J, 15, 2442, 10.1002/j.1460-2075.1996.tb00602.x · DOI
  46. Reif, 1998, Networking Rho family GTPases in lymphocytes, Immunity, 8, 395, 10.1016/S1074-7613(00)80545-2 · DOI
  47. Iritani, 1997, Control of B cell development by Ras-mediated activation of Raf, EMBO (Eur Mol Biol Organ) J, 16, 7019, 10.1093/emboj/16.23.7019 · DOI
  48. Crompton, 1996, The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte, Cell, 86, 243, 10.1016/S0092-8674(00)80096-3 · DOI
  49. Swan, 1995, Involvement of p21ras distinguishes positive and negative selection in thymocytes, EMBO (Eur Mol Biol Organ) J, 14, 276, 10.1002/j.1460-2075.1995.tb07001.x · DOI
  50. Alberola-Ila, 1995, Selective requirement for MAP kinase activation in thymocyte differentiation, Nature, 373, 620, 10.1038/373620a0 · DOI
  51. Kisielow, 1995, Development and selection of T cells: facts and puzzles, Adv Immunol, 58, 87, 10.1016/S0065-2776(08)60620-3 · DOI

Cited by

Sorted by citations

See all 75

Metadata

Authors
Shaw, A. C., Swat, W., Ferrini, R., Davidson, L., & Alt, F. W.
Affiliations
From the *Howard Hughes Medical Institute, Boston, Massachusetts 02115; ‡The Children's Hospital, Boston, Massachusetts 02115; the §Center for Blood Research and the ‖Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115; and the ¶Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
Venue
The Journal of Experimental Medicine
Publisher
Rockefeller University Press
Published
1999-01-04
Volume
189
Issue
1
Pages
123-129
ISSN
  • 0022-1007
  • 1540-9538
DOI
10.1084/jem.189.1.123
PMC
PMC1887686
Cited by
75
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review